Positron is well-branded within the field of nuclear cardiology. Positron’s business strategy is to provide a comprehensive nuclear cardiology solution. Our goal is to vertically integrate the key components of imaging technologies, clinical services, radiopharmaceutical manufacturing, processing & distribution and radioisotope production & supply. We strive to maximize market share by offering cost-effective, value added solutions to end-users. Positron is actively pursuing key initiatives to ensure the growth and longevity of the company, as well as, the industry by securing the supply of key isotopes, providing necessary radiopharmaceuticals that apply to both PET and SPECT imaging modalities and offering attractive financing solutions.
